Ganymed Pharmaceuticals AG
Records under this name other than the patents Ganymed Pharmaceuticals AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Ganymed Pharmaceuticals AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,875,424 | Identification of Tumour-Associated Cell Surface Antigens for Diagnosis and Therapy now held by BioNTech SE In force · High confidence | In force | High confidence | |
| US 10,017,564 | Monoclonal Antibodies Against CLAUDIN-18 for Treatment of Cancer now held by Tron - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbH - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbH In force · Low confidence | In force | Low confidence | |
| US 10,738,108 | Monoclonal Antibodies Against CLAUDIN-18 for Treatment of Cancer now held by Tron - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH In force · Low confidence | In force | Low confidence | |
| US 11,739,139 | Monoclonal Antibodies Against CLAUDIN-18 for Treatment of Cancer conveyed to Astellas Pharma Inc. In force · High confidence | In force | High confidence | |
| US 9,751,934 | Monoclonal Antibodies Against CLAUDIN-18 for Treatment of Cancer now held by Astellas Pharma Inc. In force · High confidence | In force | High confidence | |
| US 10,174,104 | Monoclonal Antibodies Against CLAUDIN-18 for Treatment of Cancer now held by Tron - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH In force · High confidence | In force | High confidence | |
| US 9,044,382 | Genetic Products Differentially Expressed in Tumors and the Use Thereof now held by Astellas Pharma Inc. In force · High confidence | In force | High confidence | |
| US 8,168,427 | Monoclonal Antibodies Against CLAUDIN-18 for Treatment of Cancer now held by Astellas Pharma Inc. In force · High confidence | In force | High confidence | |
| US 9,212,228 | Monoclonal Antibodies Against Claudin-18 for Treatment of Cancer now held by Astellas Pharma Inc. In force · High confidence | In force | High confidence | |
| US 9,090,940 | Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy now held by BioNTech SE In force · Medium confidence | In force | Medium confidence |